查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555776

胰高血糖素输送设备市场，按类型、按配销通路、按应用、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Glucagon Delivery Devices Market, By Type, By Distribution Channel, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年胰高血糖素输送设备市场规模为21.5042亿美元，2024年至2032年复合年增长率为8.72%。

胰高血糖素传输设备市场-市场动态

糖尿病盛行率上升推动了对胰高血糖素输送设备的需求

糖尿病盛行率的激增显着增加了对胰高血糖素输送设备的需求。据国际糖尿病联盟称，全球有超过 4.5 亿人患有糖尿病，因此迫切需要胰高血糖素等有效的紧急治疗方法。例如，美国糖尿病协会报告称，严重的低血糖发作需要给予胰高血糖素，影响很大一部分糖尿病患者，特别是第 1 型糖尿病患者。作为回应，礼来公司等公司正在扩大其产品线并改进设备技术，以满足不断增长的需求。此外，美国和欧洲的健康倡议强调更好的糖尿病管理解决方案，进一步加速先进胰高血糖素输送设备的采用。这些努力凸显了胰高血糖素设备在管理糖尿病相关紧急情况和确保更好的患者治疗结果方面的关键作用。

胰高血糖素传输设备市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.72% 左右的复合年增长率成长

根据类型细分，自动注射器预计将在 2023 年显示最大的市场份额

从配销通路细分来看，零售药局是2023年的主导类型

按应用细分，2023年应急包为主导类型

按地区划分，北美是 2023 年的主要收入来源

胰高血糖素输送设备市场細項分析：

全球胰高血糖素输送设备市场根据类型、配销通路、应用、最终用户和地区进行细分。

市场依类型分为四大类：预充式註射器、自动注射器、鼻喷剂和无针注射器。自动注射器因其易于使用且在紧急情况下有效而具有最高优先级。预装注射器紧随其后，因其方便而受到重视。鼻喷剂越来越受欢迎，而无针注射器虽小众，但正在不断增长。

根据配销通路，市场分为三类：医院药房、零售药房和线上药房。零售药局因其广泛的可及性和患者的熟悉度而处于领先地位。医院药房紧随其后，满足医院内的需求和紧急情况。网路药局不断发展，为家庭使用提供了便利和广泛的选择。

胰高血糖素传输设备市场 - 地理洞察

胰高血糖素输送设备市场呈现不同的区域动态，其中北美由于糖尿病盛行率高和医疗基础设施先进而处于领先地位。在美国，超过 3000 万人患有糖尿病，这推动了对有效胰高血糖素输送解决方案的需求。美国糖尿病协会的倡议，例如推广更好的管理工具，进一步促进了市场成长。欧洲紧随其后，德国和英国等国家投资先进的糖尿病照护技术。德国最近对糖尿病研究和开发的资助凸显了该地区对改进胰高血糖素输送设备的承诺。由于糖尿病发病率上升和医疗保健投资增加，亚太地区，特别是中国和印度，正在迅速崛起。例如，中国的国家卫生计画的重点是加强糖尿病管理基础设施，这正在扩大胰高血糖素输送设备的市场。这些区域性努力反映出全球日益关注改善糖尿病照护和紧急治疗选择。

胰高血糖素输送设备市场-竞争格局：

胰高血糖素输送设备市场竞争激烈，礼来公司、诺和诺德和赛诺菲等主要参与者处于领先地位。例如，礼来公司（Eli Lilly）一直透过策略合作扩大其市场占有率； 2022年，该公司与 Dexcom 合作，将胰高血糖素输送与连续血糖监测系统集成，以提高糖尿病管理的有效性。诺和诺德也透过在 2021 年收购糖尿病科技公司 Glooko 来巩固其地位，旨在利用 Glooko 的数位健康解决方案来补充其胰高血糖素输送设备。主要竞争对手赛诺菲一直积极进行研发，专注于提高胰高血糖素自动注射器的易用性和可靠性。这些策略性倡议和合作反映了参与者对推动胰高血糖素输送技术和满足日益增长的糖尿病护理需求的承诺。

最新进展：

2019 年 9 月，Xeris Pharmaceuticals 的 G-Voke 获得 FDA 批准，这是首款即用型、室温稳定的液体胰高血糖素，用于治疗 2 岁及以上糖尿病患者的严重低血糖。 G-Voke 提供了比传统胰高血糖素急救包更简单、更快捷的替代方案。

目录

第 1 章：胰高血糖素输送设备市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 依类型分類的胰高血糖素输送设备市场片段
    • 依配销通路分類的胰高血糖素输送设备市场片段
    • 胰高血糖素输送设备市场片段（依应用）
    • 最终用户的胰高血糖素传输设备市场片段
    • 按国家/地区分類的胰高血糖素输送设备市场片段
    • 按地区分類的胰高血糖素输送设备市场片段
  • 竞争洞察

第 3 章：胰高血糖素输送设备主要市场趋势

  • 胰高血糖素输送设备市场驱动因素
    • 市场驱动因素的影响分析
  • 胰高血糖素传输设备市场限制
    • 市场限制影响分析
  • 胰高血糖素输送装置的市场机会
  • 胰高血糖素输送设备市场未来趋势

第 4 章：胰高血糖素输送装置产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：胰高血糖素输送设备市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：胰高血糖素输送设备市场格局

  • 2023 年胰高血糖素输送设备市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：胰高血糖素输送设备市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 预充式註射器
    • 自动注射器
    • 鼻喷剂
    • 无针注射器

第 8 章：胰高血糖素输送设备市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 医院药房
    • 零售药局
    • 网路药局

第 9 章：胰高血糖素输送设备市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 紧急包
    • 糖尿病患者
    • 诊断测试

第 10 章：胰高血糖素输送设备市场 - 按下最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 家庭护理设置
    • 紧急医疗服务

第 11 章：胰高血糖素输送设备市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 胰高血糖素输送装置北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按配销通路）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲胰高血糖素传输装置主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按配销通路）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区胰高血糖素传输设备主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模和预测（按配销通路）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲胰高血糖素传输装置主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 胰高血糖素输送装置中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按配销通路）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 胰高血糖素输送设备产业

  • 竞争仪表板
  • 公司简介
    • Amphastar Pharmaceuticals, Inc.
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Eli Lilly and Company
    • Fresenius Kabi AG
    • GlaxoSmithKline plc
    • Kaleo, Inc.
    • Medtronic plc
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Sandoz International GmbH
    • Sanofi SA
    • Wockhardt Limited
    • Xeris Pharmaceuticals, Inc.
    • Ypsomed AG
    • Zealand Pharma A/S
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3731

REPORT HIGHLIGHT

Glucagon Delivery Devices Market size was valued at USD 2,150.42 million in 2023, expanding at a CAGR of 8.72% from 2024 to 2032.

The Glucagon Delivery Devices Market is experiencing significant growth due to the increasing prevalence of diabetes and the rising demand for efficient glucose management solutions. Glucagon delivery devices are used to administer glucagon, a hormone that raises blood glucose levels, in emergencies such as severe hypoglycemia. The market is bolstered by technological advancements, including the development of more user-friendly and precise delivery systems. For instance, a recent survey indicated that over 70% of endocrinologists prefer devices with automated features to ensure accurate dosing. However, the market faces challenges such as the high cost of advanced devices and the need for patient education on proper usage. Opportunities exist to expand personalized and connected glucagon delivery systems that integrate with digital health platforms. For example, the integration of smart technology into glucagon delivery devices is expected to enhance patient compliance and overall diabetes management.

Glucagon Delivery Devices Market- Market Dynamics

Rising Diabetes Prevalence Drives Demand for Glucagon Delivery Devices

The surge in diabetes prevalence is significantly boosting the demand for glucagon-delivery devices. According to the International Diabetes Federation, over 450 million people worldwide are living with diabetes, creating a substantial need for effective emergency treatments like glucagon. For instance, the American Diabetes Association reports that severe hypoglycemic episodes, which require glucagon administration, affect a significant portion of diabetic patients, particularly those with type 1 diabetes. In response, companies such as Eli Lilly are expanding their product lines and improving device technology to meet the growing demand. Additionally, health initiatives in the U.S. and Europe are emphasizing better diabetes management solutions, further accelerating the adoption of advanced glucagon delivery devices. These efforts highlight the critical role of glucagon devices in managing diabetes-related emergencies and ensuring better patient outcomes.

Glucagon Delivery Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.72% over the forecast period (2024-2032)

Based on Type segmentation, Auto-Injectors were predicted to show maximum market share in the year 2023

Based on Distribution Channel segmentation, Retail Pharmacies were the leading type in 2023

Based on Application segmentation, Emergency Kits was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Glucagon Delivery Devices Market- Segmentation Analysis:

The Global Glucagon Delivery Devices Market is segmented on the basis of Type, Distribution Channel, Application, End-User, and Region.

The market is divided into four categories based on Type: Prefilled Syringes, Auto-Injectors, Nasal Sprays, and Needle-Free Injectors. Auto-injectors hold the highest priority due to their ease of use and effectiveness in emergencies. Prefilled Syringes follow, valued for their convenience. Nasal Sprays are gaining traction, while Needle-Free Injectors are niche but growing.

The market is divided into three categories based on Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Retail Pharmacies lead due to their widespread accessibility and patient familiarity. Hospital Pharmacies follow, catering to in-hospital needs and emergency situations. Online Pharmacies are growing, offering convenience and a broad selection for home use.

Glucagon Delivery Devices Market- Geographical Insights

The Glucagon Delivery Devices Market shows varied regional dynamics, with North America leading due to high diabetes prevalence and advanced healthcare infrastructure. In the U.S., over 30 million people have diabetes, driving demand for effective glucagon delivery solutions. The American Diabetes Association's initiatives, such as the promotion of better management tools, further bolster market growth. Europe follows, with countries like Germany and the U.K. investing in advanced diabetes care technologies. Germany's recent funding for diabetes research and development highlights the region's commitment to improving glucagon delivery devices. The Asia-Pacific region, notably China and India, is emerging rapidly due to increasing diabetes rates and rising healthcare investments. For instance, China's national health initiatives are focusing on enhancing diabetes management infrastructure, which is expanding the market for glucagon delivery devices. These regional efforts reflect a growing global focus on improving diabetes care and emergency treatment options.

Glucagon Delivery Devices Market- Competitive Landscape:

The Glucagon Delivery Devices Market is highly competitive, with major players such as Eli Lilly and Company, Novo Nordisk, and Sanofi at the forefront. Eli Lilly, for example, has been expanding its market presence through strategic collaborations; in 2022, the company partnered with Dexcom to integrate glucagon delivery with continuous glucose monitoring systems, enhancing the effectiveness of diabetes management. Novo Nordisk has also strengthened its position by acquiring the diabetes technology company, Glooko, in 2021, aiming to leverage Glooko's digital health solutions to complement its glucagon delivery devices. Sanofi, a key competitor, has been active in research and development, focusing on improving the ease of use and reliability of its glucagon auto-injectors. These strategic initiatives and collaborations reflect the players' commitment to advancing glucagon delivery technologies and meeting the growing demands of diabetes care.

Recent Developments:

In September 2019, Xeris Pharmaceuticals received FDA approval for G-Voke, the first ready-to-use, room-temperature stable liquid glucagon for severe hypoglycemia in diabetes patients aged 2 and above. G-Voke offers a simpler, faster alternative to traditional glucagon emergency kits.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GLUCAGON DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amphastar Pharmaceuticals, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Kaleo, Inc.
  • Medtronic plc
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Wockhardt Limited
  • Xeris Pharmaceuticals, Inc.
  • Ypsomed AG
  • Zealand Pharma A/S
  • Others

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prefilled Syringes
  • Auto-Injectors
  • Nasal Sprays
  • Needle-Free Injectors

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Emergency Kits
  • Diabetic Patients
  • Diagnostic Testing

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Homecare Settings
  • Emergency Medical Services

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Glucagon Delivery Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Glucagon Delivery Devices Market Snippet by Type
    • 2.1.2. Glucagon Delivery Devices Market Snippet by Distribution Channel
    • 2.1.3. Glucagon Delivery Devices Market Snippet by Application
    • 2.1.4. Glucagon Delivery Devices Market Snippet by End-User
    • 2.1.5. Glucagon Delivery Devices Market Snippet by Country
    • 2.1.6. Glucagon Delivery Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Glucagon Delivery Devices Key Market Trends

  • 3.1. Glucagon Delivery Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Glucagon Delivery Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Glucagon Delivery Devices Market Opportunities
  • 3.4. Glucagon Delivery Devices Market Future Trends

4. Glucagon Delivery Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Glucagon Delivery Devices Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Glucagon Delivery Devices Market Landscape

  • 6.1. Glucagon Delivery Devices Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Glucagon Delivery Devices Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Prefilled Syringes
    • 7.1.3. Auto-Injectors
    • 7.1.4. Nasal Sprays
    • 7.1.5. Needle-Free Injectors

8. Glucagon Delivery Devices Market - By Distribution Channel

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 8.1.2. Hospital Pharmacies
    • 8.1.3. Retail Pharmacies
    • 8.1.4. Online Pharmacies

9. Glucagon Delivery Devices Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Emergency Kits
    • 9.1.3. Diabetic Patients
    • 9.1.4. Diagnostic Testing

10. Glucagon Delivery Devices Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Homecare Settings
    • 10.1.5. Emergency Medical Services

11. Glucagon Delivery Devices Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Glucagon Delivery Devices Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Glucagon Delivery Devices Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Glucagon Delivery Devices Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Glucagon Delivery Devices Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Glucagon Delivery Devices Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Glucagon Delivery Devices Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Amphastar Pharmaceuticals, Inc.
    • 12.2.2. Baxter International Inc.
    • 12.2.3. Becton, Dickinson and Company
    • 12.2.4. Eli Lilly and Company
    • 12.2.5. Fresenius Kabi AG
    • 12.2.6. GlaxoSmithKline plc
    • 12.2.7. Kaleo, Inc.
    • 12.2.8. Medtronic plc
    • 12.2.9. Novo Nordisk A/S
    • 12.2.10. Pfizer Inc.
    • 12.2.11. Sandoz International GmbH
    • 12.2.12. Sanofi S.A.
    • 12.2.13. Wockhardt Limited
    • 12.2.14. Xeris Pharmaceuticals, Inc.
    • 12.2.15. Ypsomed AG
    • 12.2.16. Zealand Pharma A/S
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us